BEIJING, Oct. 13, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company") which develops, assembles, markets and sells medical devices and wearable sleep respiratory products in China, today announced that the Company plans to release its financial results for the first half of 2014 ended June 30, 2014 on Friday, October 17, 2014.

Company management will host a conference call for investors at 8:30 a.m. EDT on Friday October 17, 2014 (8:30 PM Beijing/Hong Kong time on October 17) to review the company's financial results and to respond to investor questions and comments.

Interested parties may access the call by dialing:
Live Participant Dial In (From China): +86-10-59321988
Live Participant Dial In (From USA):  +1-866-332-6005
Code: 71944058

For those unable to participate, the call will be available as a live, listen-only webcast on the Company's website at and

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including medical devices and wearable sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on six patents and eleven software copyrights. More information may be found at

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited         +86 10-5166-0080         Janice Wang